Marie Morfouace

925 citations
25 papers · 503 indexed · h-index 10
Topics
Glioma Diagnosis and Treatment (7 papers)Cancer Genomics and Diagnostics (7 papers)Cancer Immunotherapy and Biomarkers (5 papers)

In The Last Decade

Marie Morfouace

23 papers receiving 501 citations

Peers

Marie Morfouace
Comparison fields: 5 of 69
  • Molecular Biology 281
  • Cancer Research 162
  • Genetics 139
  • Oncology 91
  • Epidemiology 75
Replace Britt Hanson with:
Britt Hanson United Kingdom
Josiah N. Orina United States
Kedar Inamdar United States
Aaron Elliott United States
Maja Ludvigsen Denmark
Zahra Asgari United States
Jamie Sheren United States
Neil Kernohan United Kingdom
Andrey Sudarikov Russia
Heather Bendall United States
Marie Morfouace relative to Britt Hanson United Kingdom Britt Hanson's profile →
Citations per field
00.5×2.5×
Britt Hanson · 1×
Citations per year

Countries citing papers authored by Marie Morfouace

Since Specialization
Citations

This map shows the geographic impact of Marie Morfouace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Morfouace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Morfouace more than expected).

Fields of papers citing papers by Marie Morfouace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Morfouace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Morfouace. The network helps show where Marie Morfouace may publish in the future.

Co-authorship network of co-authors of Marie Morfouace

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Morfouace. A scholar is included among the top collaborators of Marie Morfouace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Morfouace. Marie Morfouace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 2
3 0
4 0
5 7
6 1
7 7
8 13
9 1
10 28
11 1
12 2
13 21
14 121
15 29
16 11
17 99
18 72
19 16
20 55

About Marie Morfouace

Marie Morfouace is a scholar working on Cancer Research, Genetics and Gastroenterology, having authored 25 papers that have together received 503 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Genetics (139 citations), Cancer Research (162 citations) and Molecular Biology (281 citations). Marie Morfouace has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Martine F. Roussel, Anang A. Shelat, Lisa Oliver, Lisenn Lalier, François M. Vallette, Mathilde Cheray, Claire Pecqueur, Pierre‐François Cartron, Svetlana Rezinciuc and Heather S. Smallwood. Their work appears in journals such as Journal of Biological Chemistry, Cancer Cell and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026